The American Journal of Medicine
Volume 123, Issue 4 , Pages 335-341, April 2010

Does Vitamin D Modulate Asymmetric Dimethylarginine and C-Reactive Protein Concentrations?

  • Doan T. Ngo, BPharm, PhD

      Affiliations

    • Department of Pharmacy, University of South Australia, South Australia, Australia
    • Vascular Disease and Therapeutics Research Group, Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia
  • ,
  • Aaron L. Sverdlov, MBBS

      Affiliations

    • Vascular Disease and Therapeutics Research Group, Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia
  • ,
  • John J. McNeil, MBBS, PhD

      Affiliations

    • Monash University, Department of Epidemiology and Preventive Medicine, Victoria, Australia
  • ,
  • John D. Horowitz, MBBS, PhD

      Affiliations

    • Vascular Disease and Therapeutics Research Group, Basil Hetzel Institute, The Queen Elizabeth Hospital, Department of Medicine, The University of Adelaide, Australia
    • Corresponding Author InformationReprint requests should be addressed to John D. Horowitz, MBBS, PhD, Vascular Disease and Therapeutics Research Group, Basil Hetzel Institute, The Queen Elizabeth Hospital, University of Adelaide, 28 Woodville Rd, Woodville South, South Australia, 5011

Abstract 

Background

Vitamin D deficiency is associated with significant increases in the incidence of cardiovascular risk factors and mortality. However, the mechanisms underlying this association remain unclear. The current study evaluated the possible relationships among vitamin D status, endothelial dysfunction, and inflammation.

Methods

Plasma concentrations of 25-hydroxyvitamin D3 were determined by radioimmunoassay in a normal population cohort (n=253) aged 51 to 77 years (mean 63.4±6 years). Asymmetric dimethylarginine, a marker/mediator of endothelial dysfunction, was assayed by high-performance liquid chromatography. High-sensitivity C-reactive protein levels were used as a marker of inflammatory activation.

Results

On univariate analyses, low 25-hydroxyvitamin D3 levels were inversely correlated with asymmetric dimethylarginine concentrations, high-sensitivity C-reactive protein levels, and body mass index. Seasonal fluctuations in 25-hydroxyvitamin D3 levels were associated with reciprocal asymmetric dimethylarginine concentration fluctuations. Hypertension and treatment with an angiotensin-converting enzyme inhibitor/angiotensin receptor blocker also were associated with low 25-hydroxyvitamin D3 levels. On multiple linear analysis, both asymmetric dimethylarginine (β=−0.19, P=.003) and high-sensitivity C-reactive protein (β=−0.14, P=.03) concentrations were inversely correlated with plasma 25-hydroxyvitamin D3 concentrations; other significant correlates were male gender (β=0.19, P=.003), calcium levels (β=0.14, P=.03), and use of angiotensin-converting enzyme inhibitor (β=−0.17, P=.007).

Conclusion

Low 25-hydroxyvitamin D3 levels are associated with markers of endothelial dysfunction and inflammatory activation, representing potential mechanisms for incremental coronary risk.

Keywords: Asymmetric dimethylarginine, Cardiovascular risk, Endothelial dysfunction, High-sensitivity C-reactive protein, Vitamin D

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funding: This work was supported in part by research grants from the National Health and Medical Research Council and National Heart Foundation of Australia.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

 Authorship: All authors had access to the data and played a role in writing this manuscript.

PII: S0002-9343(09)01014-6

doi:10.1016/j.amjmed.2009.09.024

The American Journal of Medicine
Volume 123, Issue 4 , Pages 335-341, April 2010